Nilsson, Jonas http://orcid.org/0000-0002-2829-5563
Piovesana, Vittoria
Turini, Marco
Lezzi, Claudio
Eriksson, Jennifer
Aapro, Matti
Article History
Received: 13 December 2021
Accepted: 13 August 2022
First Online: 8 September 2022
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: Jonas Nilsson and Jennifer Eriksson are employees of Icon plc. Icon plc. received funding from Helsinn Healthcare SA for study design, execution, analysis and manuscript development. Vittoria Piovesana and Marco Turini are employees of Helsinn Healthcare SA. Helsinn Healthcare commercializes AKYNZEO® (netupitant palonosetron) worldwide. AKYNZEO® (netupitant palonosetron) is the subject of the present economic analysis. Matti Aapro has been a consultant for many companies developing antiemetics, including Helsinn.